DOI: 10.1128/AAC.48.6.2166-2172.2004
Article Information
PubMed
Published By
History
- Received November 3, 2003
- Returned for modification December 12, 2003
- Accepted February 4, 2004
- Published online May 21, 2004.
Copyright & Usage
Copyright © 2004 American Society for Microbiology
Author Information
- Thomas J. Walsh1*,
- Mats O. Karlsson2,
- Timothy Driscoll3,
- Adriano G. Arguedas4,
- Peter Adamson5,6,
- Xavier Saez-Llorens7,
- Ajay J. Vora8,
- Antonio C. Arrieta9,
- Jeffrey Blumer6,10,
- Irja Lutsar11,
- Peter Milligan11 and
- Nolan Wood11
- 1National Cancer Institute and
- 6Pediatric Pharmacology Unit, National Institute of Child Health and Human Development
- 2Bethesda, Maryland; Uppsala University, Uppsala, Sweden
- 3Duke University Medical Center, Durham, North Carolina
- 4Instituto Costarricense de Invetigaciones Clinicas and National Children's Hospital, San Jose, Costa Rica
- 5Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- 7Hospital del Niños, Ciudad de Panama, Panama
- 8Sheffield Children's Hospital, Sheffield
- 11Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
- 9Children's Hospital of Orange County, Orange, California
- 10University Hospitals of Cleveland, Cleveland, Ohio
- ↵* Corresponding author. Mailing address: Pediatric Oncology Branch, National Cancer Institute, Bldg. 10, Rm. 13N240, Bethesda, MD 20892. Phone: (301) 496-7103. Fax: (301) 402-0575. E-mail: walsht{at}mail.nih.gov .